Alicon Pharmaceutical Private Limited

Alicon Pharmaceutical Private Limited - pharma in Palghar, Maharashtra, India. FY 2026 financials & compliance.
CIN U99999MH1995PTC086137 Incorporated 07 March 1995 ROC Mumbai HQ Palghar, Maharashtra, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2024
₹28.34 Cr
▲ 28% YoY
Net profit · FY 2024
₹56.12 Lakh
Net margin 2%
EBITDA · FY 2024
₹1.25 Cr
EBITDA margin 4.4%
Authorised capital
₹75 Lakh
Registered with MCA
Paid-up capital
₹75 Lakh
Issued & subscribed
Open charges
₹29.5 Cr
Satisfied ₹7.84 Cr
Company age
31 yrs
Est. 1995
Employees · EPFO
56
Provident fund records

About Alicon Pharmaceutical Private Limited

Data last updated:

Alicon Pharmaceutical Private Limited is a private limited company based in Palghar, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 March 1995 and has been in existence for over 31 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U99999MH1995PTC086137. Its GSTIN is 24AAACA4201E1ZL (Gujarat). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹75 Lakh. It is led by directors including Nitinbhai Popatbhai Savani and Priyank Batukbhai Savani.

Its last annual general meeting (AGM) was held on 12 November 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 147/6 Nagasai Apartment Shirgaon Road Chandansar Road Virar East Virar, Palghar, Maharashtra, India – 401305.

As per the financials filed for FY 2024, the company reported a revenue of ₹28.34 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹56.12 Lakh (net margin 2%) and EBITDA of ₹1.25 Cr (EBITDA margin 4.4%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 6% over five years.

The company has about 56 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹29.5 Cr and satisfied charges of ₹7.84 Cr on record. Court records list 11 cases involving the company, including 4 filed by the company and 7 filed against it; 7 cases are pending.

Alicon Pharmaceutical Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0002509). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aliconpharmaceuticals.com.

Company details

CIN U99999MH1995PTC086137
Registration Number 086137
Incorporation Date 07 March 1995
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 12 November 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-17-0002509
Key People
Nitinbhai Popatbhai Savani Director Priyank Batukbhai Savani Director Mayuri Priyankkumar Savani Director

Recognitions & Rankings of Alicon Pharmaceutical

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-MH-17-0002509

Contact details

Alicon Pharmaceutical Private Limited's registered office is in Palghar, Maharashtra. Its website is aliconpharmaceuticals.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    aliconpharmaceuticals.com
  • Registered Address
    147/6 Nagasai Apartment Shirgaon Road Chandansar Road Virar East Virar, Palghar, Maharashtra, India – 401305
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Alicon Pharmaceutical Private Limited, buy the company report.

Comprehensive company report
Alicon Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Alicon Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Alicon Pharmaceutical Private Limited, buy the company report.

Financials of Alicon Pharmaceutical Private Limited

FY 2024 filings available

Alicon Pharmaceutical Private Limited reported revenue of ₹28.34 Cr (up 28% YoY) for FY 2024.

Revenue · FY 2024
₹28.34 Cr ▲ 28%
Net profit · FY 2024
₹56.12 Lakh margin 2%
EBITDA · FY 2024
₹1.25 Cr margin 4.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 28%
3 years · compounded
▲ 2%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 26%
3 years · compounded
▼ 6%
5 years · compounded
▼ 2%

Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 28% growth in the latest year. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations₹28.34 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.25 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹56.12 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin4.4%
Net Profit Margin2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Alicon Pharmaceutical Private Limited, buy the company report.

Board of directors of Alicon Pharmaceutical Private Limited

Alicon Pharmaceutical has 6 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Nitinbhai Popatbhai Savani
Also directs: Kiran Wind Energy Private Limited
Director22 Oct 20188 Years 0 MonthsCurrent
Priyank Batukbhai Savani
Also directs: Satvam Pharma Private Limited
Director16 Feb 20188 Years 8 MonthsCurrent
Mayuri Priyankkumar Savani
Also directs: Gangaveda Private Limited
Director21 Mar 20224 Years 7 MonthsCurrent
Ashish Dayashanker SinghDirector01 Feb 20206 Years 9 MonthsCurrent
Anup Omprakash Tapadiya
Also directs: Satvam Pharma Private Limited, Tapadiya Interventional Technologies & Healthcare LLP, Vitalta Lifetech Private Limited
Director22 Oct 20188 Years 0 MonthsCurrent
Chandan Rajgopal Soni
Also directs: Gripil Pharmaceuticals Private Limited, Satvam Pharma Private Limited
Director16 Feb 20188 Years 8 MonthsCurrent
View all directors

Peer comparison

Alicon Pharmaceutical Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Zazen Pharma Private Limited₹28.58 Cr (FY 2025)19.0%Mumbai, Maharashtra, India
Dr. Edwin Medilabs Private Limited₹28.56 Cr (FY 2024)3.0%Kurali, Punjab, India
Biovencer Healthcare Private Limited₹28.51 Cr (FY 2025)-1.0%Greater Noida, Uttar Pradesh, India
Alicon Pharmaceutical Private Limitedthis company₹28.34 Cr (FY 2024)₹56.12 Lakh2%28.0%56Palghar, Maharashtra, India
Eisen Pharmaceutical Company (Private) Limited₹28.28 Cr (FY 2025)16.0%Pune, Maharashtra, India
Indus Pharma Private Limited₹28.11 Cr (FY 2023)-58.0%New Delhi, Delhi, India

To see the full peer comparison of Alicon Pharmaceutical Private Limited, buy the company report.

Auditor

Alicon Pharmaceutical Private Limited is audited by Aniket M. Padhey & CO for the financial year 2024.

Auditor firmFinancial yearFirm registration number
Aniket M. Padhey & COFY 2024118540W

Shareholding

The shareholding of Alicon Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Alicon Pharmaceutical Private Limited, buy the company report.

Charges & borrowings

Open charges
₹29.5 Cr
Satisfied charges
₹7.84 Cr
Breakdown by lending institutions
Bank of India₹20.00 Cr
Others₹9.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
26 Mar 2024100911266Bank of India₹20 CrOpen
11 Sep 2019100296231Others₹50 LakhOpen
20 Dec 2018100231037Others₹5 CrOpen
20 Dec 2018100250890Others₹4 CrOpen
16 Jul 201410511685Union Bank of India₹82.5 LakhSatisfied

To see the full charge records of Alicon Pharmaceutical Private Limited, buy the company report.

Total charge records: 14 View all charges

MSME payment delays

Alicon Pharmaceutical Private Limited has 16 MSME Form 1 returns on record between 2019 and 2024, listing 1,052 overdue payments to 98 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 98)

SupplierAmount dueDue sinceReported on
Universe Capsules Biotech Private Limited
Solar Polypack Industries
Venus Pharma Chem
Mehta Associates
Shreeji Packwell

To see the full MSME payment records of Alicon Pharmaceutical Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Alicon Pharmaceutical Private Limited has a workforce of 56 employees on its EPFO records as of Feb 27, 2025, across 1 active EPFO establishment.

Employee count
56
Active EPFO establishments
1
Employee growth
43.59%

GST

Alicon Pharmaceutical has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
24AAACA4201E1ZLGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Alicon Pharmaceutical Private Limited, buy the company report.

Recent activity

Alicon Pharmaceutical Private Limited has 15 board changes on record since 2018: 6 appointments and 9 cessations. The latest: Mayuri Priyankkumar Savani ceased to be Additional Director on 30 Sep 2022.

AGM
Alicon Pharmaceutical Private Limited last Annual general meeting of members was held on 12 Nov 2024 as per latest MCA records.
Filing
Alicon Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Bank Of India amounted to Rs. 2,000.00 Lakh with Charge ID 100911266 was registered on 26 Mar 2024.
Ceased
Mayuri Priyankkumar Savani ceased to be Additional Director.
Appointed
Mayuri Priyankkumar Savani was appointed as Director.
Ceased
Ashish Dayashanker Singh ceased to be Additional Director.
Ceased
Sudhir Manharilal Shah ceased to be Director.
Appointed
Ashish Dayashanker Singh was appointed as Director.
Ceased
Anup Omprakash Tapadiya ceased to be Additional Director.
Ceased
Nitinbhai Popatbhai Savani ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 100296231 was registered on 11 Sep 2019.
Charges
A charge with Others of Rs. 500.00 Lakh registered on 20 Dec 2018 with Charge ID 100231037 was modified on 11 Sep 2019.

34 earlier events are in the company report.

Frequently asked questions

Alicon Pharmaceutical is an active private limited company based in Palghar, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 March 1995 (31+ years old) and is registered under CIN U99999MH1995PTC086137.

Alicon Pharmaceutical has 6 current directors:

The latest financial statements of Alicon Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 12 November 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Alicon Pharmaceutical is 24AAACA4201E1ZL, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Alicon Pharmaceutical is U99999MH1995PTC086137. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Alicon Pharmaceutical has 11 court cases on record: 4 filed by the company and 7 filed against it. 7 are pending.

Alicon Pharmaceutical was incorporated on 07 March 1995, making it 31+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Alicon Pharmaceutical by revenue are Zazen Pharma Private Limited, Dr. Edwin Medilabs Private Limited, Biovencer Healthcare Private Limited, Eisen Pharmaceutical Company (Private) Limited, Indus Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Mayuri Priyankkumar Savani ceased to be Additional Director on 30 Sep 2022. Mayuri Priyankkumar Savani was appointed as Director on 21 Mar 2022. Ashish Dayashanker Singh ceased to be Additional Director on 31 Dec 2020. Alicon Pharmaceutical has 15 board changes on record in total.

Yes, Alicon Pharmaceutical is registered as a small enterprise under Udyam registration (number: UDYAM-MH-17-0002509).

Alicon Pharmaceutical has 16 MSME Form 1 returns on record between 2019 and 2024, listing 1,052 overdue payments to 98 micro and small suppliers. The latest return was filed on 24 Apr 2024.

Alicon Pharmaceutical can be reached through the website aliconpharmaceuticals.com. Its registered office is in Palghar, Maharashtra, India.